Patent case: Novartis AG vs. Pharmathen Global B.V., Netherlands

search-result-placeholder.jpg

In the present preliminary case a cross-border injunction was ordered by the provisions judge. He came to this conclusion because he found the product to be infringing (in contrast to a preliminary decision of the Greek court) and he found that the Dutch-based Pharmathen company was controlling the other companies in the group.

Case date: 19 July 2022

Case number: C/09/625801 / KG ZA 22-201

Court: Provisions Judge of the District Court of The Hague

A full summary of this case has been published on Kluwer IP Law.

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines